Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
20.07
+0.35 (1.77%)
At close: Nov 6, 2026, 4:00 PM EST
20.16
+0.09 (0.45%)
After-hours: Nov 6, 2026, 7:30 PM EST
Denali Therapeutics Employees
Denali Therapeutics had 507 employees as of March 31, 2026. The number of employees increased by 64 or 14.45% compared to the same quarter last year. That makes Denali Therapeutics the 19,919th largest employer in the world and 2,671st in the United States.
Employees
507
Change (1Y)
64
Growth (1Y)
14.45%
Revenue / Employee
$42,174
Profits / Employee
-$620,164
Market Cap
3.22B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 507 | 64 | 14.45% |
| Dec 31, 2025 | 503 | 81 | 19.19% |
| Sep 30, 2025 | 517 | 127 | 32.56% |
| Jun 30, 2025 | 486 | 122 | 33.52% |
| Mar 31, 2025 | 443 | 68 | 18.13% |
| Dec 31, 2024 | 422 | -23 | -5.17% |
| Sep 30, 2024 | 390 | -57 | -12.75% |
| Jun 30, 2024 | 364 | -74 | -16.89% |
| Mar 31, 2024 | 375 | -55 | -12.79% |
| Dec 31, 2023 | 445 | 18 | 4.22% |
| Sep 30, 2023 | 447 | 34 | 8.23% |
| Jun 30, 2023 | 438 | 43 | 10.89% |
| Mar 31, 2023 | 430 | 50 | 13.16% |
| Dec 31, 2022 | 427 | 47 | 12.37% |
| Sep 30, 2022 | 413 | 53 | 14.72% |
| Jun 30, 2022 | 395 | 61 | 18.26% |
| Mar 31, 2022 | 380 | 69 | 22.19% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ADMA Biologics | 647 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 289 |
| Viridian Therapeutics | 252 |
| Celcuity | 155 |
| IDEAYA Biosciences | 145 |
DNLI News
- 2 days ago - Denali Therapeutics price target raised to $42 from $40 at Morgan Stanley - TheFly
- 2 days ago - Denali Therapeutics price target raised to $24 from $23 at Wedbush - TheFly
- 3 days ago - Denali Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Denali Therapeutics Earnings release: Q3 2026 - Filings
- 3 days ago - Denali Therapeutics Quarterly report: Q3 2026 - Filings
- 3 days ago - Denali Therapeutics reports Q3 EPS 37c, consensus (37c) - TheFly
- 3 days ago - Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 7 days ago - Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product - GlobeNewsWire